Basics |
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
|
IPO Date: |
January 31, 2001 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$10.6B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.75 | 2.71%
|
Avg Daily Range (30 D): |
$0.81 | 1.48%
|
Avg Daily Range (90 D): |
$0.98 | 2.06%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.21M |
Avg Daily Volume (30 D): |
2.23M |
Avg Daily Volume (90 D): |
2.14M |
Trade Size |
Avg Trade Size (Sh.): |
103 |
Avg Trade Size (Sh.) (30 D): |
63 |
Avg Trade Size (Sh.) (90 D): |
65 |
Institutional Trades |
Total Inst.Trades: |
19,067 |
Avg Inst. Trade: |
$3.11M |
Avg Inst. Trade (30 D): |
$4.99M |
Avg Inst. Trade (90 D): |
$3.84M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
6 |
Market Closing Trades |
Avg Closing Trade: |
$9.94M |
Avg Closing Trade (30 D): |
$23.32M |
Avg Closing Trade (90 D): |
$18.58M |
Avg Closing Volume: |
172.58K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q3 2024 |
Basic EPS
|
|
$-.54
|
$-.21
|
Diluted EPS
|
|
$-.54
|
$-.21
|
Revenue
|
$
|
$ 706.79M
|
$ 708.66M
|
Gross Profit
|
$
|
$ 500.55M
|
$ 512.59M
|
Net Income / Loss
|
$
|
$ -101.22M
|
$ -38.24M
|
Operating Income / Loss
|
$
|
$ -96.01M
|
$ -39.4M
|
Cost of Revenue
|
$
|
$ 206.24M
|
$ 196.07M
|
Net Cash Flow
|
$
|
$ -259.51M
|
$ 58.65M
|
PE Ratio
|
|
|
|
|
|
|